GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹138 Cr | ₹1,705 Cr | ₹-1,757 Cr | ₹1,208 Cr | ₹-1,003 Cr |
What is the latest Cash Flow from Investing Activities ratio of GLAND PHARMA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹138 Cr |
| Mar2025 | ₹1,705 Cr |
| Mar2024 | ₹-1,757 Cr |
| Mar2023 | ₹1,208 Cr |
| Mar2022 | ₹-1,003 Cr |
How is Cash Flow from Investing Activities of GLAND PHARMA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹138 Cr | -91.92 | |
| Mar2025 | ₹1,705 Cr | Positive | |
| Mar2024 | ₹-1,757 Cr | Negative | |
| Mar2023 | ₹1,208 Cr | Positive | |
| Mar2022 | ₹-1,003 Cr | - | |
Compare Cash Flow from Investing Activities of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹48,064.5 Cr | -1.4% | 0.2% | 47.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,572.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -1.4% |
0.2% |
47.3% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses